von Willebrand factor concentrates
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeTo |
desmopressin (in some cases)
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:canBe |
plasma-derived
recombinant |
| gptkbp:contains |
gptkb:von_Willebrand_factor
factor VIII |
| gptkbp:contraindication |
known hypersensitivity to components
|
| gptkbp:derivedFrom |
human plasma
|
| https://www.w3.org/2000/01/rdf-schema#label |
von Willebrand factor concentrates
|
| gptkbp:indication |
bleeding episodes
surgical prophylaxis |
| gptkbp:marketedAs |
Humate-P
Vonvendi Wilate |
| gptkbp:monitors |
factor VIII activity
von Willebrand factor activity |
| gptkbp:notRecommendedFor |
gptkb:hemophilia_B
|
| gptkbp:riskFactor |
transmission of infectious agents (plasma-derived)
|
| gptkbp:sideEffect |
fever
headache allergic reactions thromboembolic events |
| gptkbp:storage |
refrigerated
room temperature (short term) |
| gptkbp:usedFor |
treatment of von Willebrand disease
|
| gptkbp:bfsParent |
gptkb:von_Willebrand_disease
|
| gptkbp:bfsLayer |
6
|